Publicaciones en colaboración con investigadores/as de Gustave Roussy Cancer Campus (18)

2024

  1. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆

    Annals of Oncology, Vol. 35, Núm. 2, pp. 159-182

2019

  1. Coffee and tea drinking in relation to the risk of differentiated thyroid carcinoma: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study

    European Journal of Nutrition, Vol. 58, Núm. 8, pp. 3303-3312

  2. Estimated Substitution of Tea or Coffee for Sugar-Sweetened Beverages Was Associated with Lower Type 2 Diabetes Incidence in Case-Cohort Analysis across 8 European Countries in the EPIC-InterAct Study

    Journal of Nutrition, Vol. 149, Núm. 11, pp. 1985-1993

2018

  1. Circulating fetuin - A and risk of type 2 diabetes: A mendelian randomization analysis

    Diabetes, Vol. 67, Núm. 6, pp. 1200-1205

  2. Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

    International Journal of Cancer, Vol. 142, Núm. 3, pp. 449-459

  3. Nutritional quality of food as represented by the FSAm-NPS nutrient profiling system underlying the Nutri-Score label and cancer risk in Europe: Results from the EPIC prospective cohort study

    PLoS Medicine, Vol. 15, Núm. 9

  4. Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

    International Journal of Cancer, Vol. 143, Núm. 10, pp. 2351-2358

2017

  1. Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition

    International Journal of Cancer, Vol. 140, Núm. 10, pp. 2246-2255

  2. Consumption of fish is not associated with risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition (EPIC) study

    Journal of Nutrition, Vol. 147, Núm. 7, pp. 1366-1373

2013

  1. Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project

    European Journal of Cancer, Vol. 49, Núm. 11, pp. 2565-2578

2012

  1. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe

    European Journal of Cancer, Vol. 48, Núm. 2, pp. 159-169

  2. Carcinoma of endocrine organs: Results of the RARECARE project

    European Journal of Cancer, Vol. 48, Núm. 13, pp. 1923-1931

  3. Invasive extramammary Paget's disease and the risk for secondary tumours in Europe

    European Journal of Surgical Oncology, Vol. 38, Núm. 3, pp. 214-221

2011

  1. Rare cancers are not so rare: The rare cancer burden in Europe

    European Journal of Cancer, Vol. 47, Núm. 17, pp. 2493-2511

  2. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials

    The Lancet, Vol. 378, Núm. 9793, pp. 771-784

  3. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials

    The Lancet, Vol. 378, Núm. 9793, pp. 771-784

2010

  1. The burden of rare cancers in europe

    Advances in Experimental Medicine and Biology, Vol. 686, pp. 285-303

1999

  1. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens

    American Journal of Surgical Pathology, Vol. 23, Núm. 9, pp. 1102-1108